Your browser doesn't support javascript.
loading
Identification of a combination of transcription factors that synergistically increases endothelial cell barrier resistance.
Roudnicky, Filip; Kim, Bo Kyoung; Lan, Yanjun; Schmucki, Roland; Küppers, Verena; Christensen, Klaus; Graf, Martin; Patsch, Christoph; Burcin, Mark; Meyer, Claas Aiko; Westenskow, Peter D; Cowan, Chad A.
  • Roudnicky F; Pharmaceutical Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, CH-4070, Switzerland.
  • Kim BK; Pharmaceutical Research and Early Development, Ocular Technologies, I2O, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, CH-4070, Switzerland.
  • Lan Y; Pharmaceutical Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, CH-4070, Switzerland.
  • Schmucki R; Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, CH-4070, Switzerland.
  • Küppers V; Pharmaceutical Research and Early Development, Ocular Technologies, I2O, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, CH-4070, Switzerland.
  • Christensen K; Pharmaceutical Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, CH-4070, Switzerland.
  • Graf M; Pharmaceutical Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, CH-4070, Switzerland.
  • Patsch C; Pharmaceutical Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, CH-4070, Switzerland.
  • Burcin M; Pharmaceutical Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, CH-4070, Switzerland.
  • Meyer CA; Pharmaceutical Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, CH-4070, Switzerland.
  • Westenskow PD; Pharmaceutical Research and Early Development, Ocular Technologies, I2O, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, CH-4070, Switzerland. peter.westenskow@roche.com.
  • Cowan CA; Department of Medicine, Division of Cardiology, Beth Israel Deaconess Medical Center (BIDMC), Harvard Medical School, Boston, Massachusetts, 02215, USA. ccowan@bidmc.harvard.edu.
Sci Rep ; 10(1): 3886, 2020 03 03.
Article en En | MEDLINE | ID: mdl-32127614
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Factores de Transcripción / Células Endoteliales Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Factores de Transcripción / Células Endoteliales Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article